| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |